应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
CAPR Capricor Therapeutics Inc
未开盘 11-18 16:00:00 EST
18.38
-0.23
-1.24%
盘后
17.56
-0.82
-4.46%
19:21 EST
最高
19.47
最低
17.21
成交量
121.62万
今开
18.66
昨收
18.61
日振幅
12.14%
总市值
8.36亿
流通市值
6.71亿
总股本
4,547万
成交额
2,226万
换手率
3.33%
流通股本
3,649万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Capricor Therapeutics, Inc.盘中异动 股价大跌5.05%报17.67美元
市场透视 · 11-18 22:40
Capricor Therapeutics, Inc.盘中异动 股价大跌5.05%报17.67美元
美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals
路透中文 · 11-18 15:15
美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals
Capricor Therapeutics, Inc.盘中异动 股价大跌5.03%报17.19美元
市场透视 · 11-14
Capricor Therapeutics, Inc.盘中异动 股价大跌5.03%报17.19美元
Capricor Therapeutics Inc 预计每股亏损36美分 - 财报前瞻
Reuters · 11-12
Capricor Therapeutics Inc 预计每股亏损36美分 - 财报前瞻
Capricor Therapeutics, Inc.盘中异动 股价大跌5.02%报20.29美元
市场透视 · 11-01
Capricor Therapeutics, Inc.盘中异动 股价大跌5.02%报20.29美元
Capricor Therapeutics, Inc.盘中异动 急速上涨5.00%
市场透视 · 10-25
Capricor Therapeutics, Inc.盘中异动 急速上涨5.00%
Capricor Therapeutics, Inc.盘中异动 股价大涨5.01%报21.15美元
市场透视 · 10-24
Capricor Therapeutics, Inc.盘中异动 股价大涨5.01%报21.15美元
Capricor Therapeutics, Inc.盘中异动 大幅拉升5.36%
市场透视 · 10-21
Capricor Therapeutics, Inc.盘中异动 大幅拉升5.36%
美国研究综述-中心空间、吉利德、Gitlab
Reuters · 10-21
美国研究综述-中心空间、吉利德、Gitlab
美国研究综述-美国运通、Capricor Therapeutics、旅行者
Reuters · 10-21
美国研究综述-美国运通、Capricor Therapeutics、旅行者
美国研究综述-美国运通、Capricor Therapeutics、旅行者
Reuters · 10-21
美国研究综述-美国运通、Capricor Therapeutics、旅行者
BUZZ--美国股票走势-艾利丹尼森、Snap-On、Avadel Pharma
Reuters · 10-18
BUZZ--美国股票走势-艾利丹尼森、Snap-On、Avadel Pharma
Capricor Therapeutics, Inc.盘中异动 股价大跌8.78%
市场透视 · 10-17
Capricor Therapeutics, Inc.盘中异动 股价大跌8.78%
BUZZ--美国股票走势-Meta Platforms、Elevance Health、Robinhood Markets
Reuters · 10-17
BUZZ--美国股票走势-Meta Platforms、Elevance Health、Robinhood Markets
BUZZ-Capricor Therapeutics 因定价发行 7,500 万美元股票而下跌
Reuters · 10-17
BUZZ-Capricor Therapeutics 因定价发行 7,500 万美元股票而下跌
BUZZ-Capricor Therapeutics 因计划发行股票而下跌
Reuters · 10-17
BUZZ-Capricor Therapeutics 因计划发行股票而下跌
Capricor Therapeutics, Inc.盘中异动 早盘急速下跌5.00%报20.52美元
市场透视 · 10-16
Capricor Therapeutics, Inc.盘中异动 早盘急速下跌5.00%报20.52美元
Capricor Therapeutics, Inc.盘中异动 早盘大幅上涨5.16%
市场透视 · 10-15
Capricor Therapeutics, Inc.盘中异动 早盘大幅上涨5.16%
Capricor Therapeutics, Inc.盘中异动 快速拉升5.01%
市场透视 · 10-14
Capricor Therapeutics, Inc.盘中异动 快速拉升5.01%
BUZZ--美国股票走势-沃尔玛、加密货币、银行
Reuters · 10-12
BUZZ--美国股票走势-沃尔玛、加密货币、银行
加载更多
公司概况
公司名称:
Capricor Therapeutics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,专注于开发转化细胞和外泌体疗法,用于治疗Duchenne肌营养不良症(DMD),这是一种罕见的肌肉营养不良症,会导致肌肉退化和过早死亡,以及其他医疗需求未得到满足的疾病。自成立以来,该公司投入了大量资源开发CAP-1002和他们的其他候选产品,包括他们的外泌体平台,开发他们的制造流程,为公司配备人员,并为这些业务提供行政支持。该公司没有任何获准销售的产品。公司能否最终产生足以实现盈利的任何产品收入,将取决于用于治疗DMD和其他候选产品的CAP-1002的成功开发、批准和最终商业化。
发行价格:
--
{"stockData":{"symbol":"CAPR","market":"US","secType":"STK","nameCN":"Capricor Therapeutics Inc","latestPrice":18.38,"timestamp":1731963600000,"preClose":18.61,"halted":0,"volume":1216185,"hourTrading":{"tag":"盘后","latestPrice":17.5607,"preClose":18.38,"latestTime":"19:21 EST","volume":4802,"amount":88201.3398,"timestamp":1731975676519},"delay":0,"floatShares":36493800,"shares":45469908,"eps":-1.074378,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.23,"latestTime":"11-18 16:00:00 EST","open":18.66,"high":19.47,"low":17.21,"amount":22263326.93832,"amplitude":0.12144,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.074378,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"adjPreClose":18.61,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":18.71,"preClose":18.61,"latestTime":"09:29 EST","volume":7870,"amount":149002.45815999998,"timestamp":1731940195071},"postHourTrading":{"tag":"盘后","latestPrice":17.5607,"preClose":18.38,"latestTime":"19:21 EST","volume":4802,"amount":88201.3398,"timestamp":1731975676519},"volumeRatio":0.926677,"impliedVol":1.1409,"impliedVolPercentile":0.4382},"requestUrl":"/m/hq/s/CAPR","defaultTab":"news","newsList":[{"id":"2484676521","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.05%报17.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676521?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:40","pubTimestamp":1731940848,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时40分,Capricor Therapeutics, Inc.股票出现波动,股价大幅跳水5.05%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.09%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822404998e4341a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822404998e4341a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2484661939","title":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2484661939","media":"路透中文","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484661939?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:15","pubTimestamp":1731914144,"startTime":"0","endTime":"0","summary":"美国研究综述-Airbnb、Post Holdings、Syndax Pharmaceuticals路透11月18日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Airbnb、Post Holdings 和 Syndax Pharmaceuticals。* Post Holdings Inc POST.N:摩根大通将目标价从125美元上调至135美元 * Syndax Pharmaceuticals Inc SNDX.O:杰富瑞将目标价从37美元上调至43美元 * Transmedics Group Inc TMDX.O:TD Cowen将目标价从175美元下调至120美元以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4S3MP0GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBI","BK1502","CAPR","IE00BZ08YR35.GBP","HK0000306701.USD","LU1481107354.HKD","YELP","TMDX","LU1439103000.SGD","IE00BZ08YT58.USD","KRRO","LU0051755006.USD","IE00B19Z9Z06.USD","PCOR","LU0543330483.HKD","LU0348788117.USD","HBBD.SI","LU1023057109.AUD","IE00BFMHRM44.USD","LU0228367735.SGD","LU0345776255.USD","LU0287142896.SGD","89988","LU0737861772.HKD","PGR","LU1983260115.SGD","09988","LU1048588211.SGD","BABA","EFXT","LU0516422440.USD","LU1688375341.USD","LU2355687059.USD","SNDX","LU0898667661.SGD","LU0543330566.HKD","LU0541502299.USD","TARS","INO","LU0293314216.USD","OVV","BK1521","ADSK","LU1196710864.SGD","BK4503","LU0251144936.SGD","LU1105468828.SGD","POST","ABNB","PLD"],"gpt_icon":1},{"id":"2483683096","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.03%报17.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483683096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483683096?lang=zh_cn&edition=full","pubTime":"2024-11-14 01:59","pubTimestamp":1731520781,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日01时59分,Capricor Therapeutics, Inc.股票出现波动,股价急速下挫5.03%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.19%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114015941a234bfe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114015941a234bfe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2482757714","title":"Capricor Therapeutics Inc 预计每股亏损36美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482757714","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482757714?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:50","pubTimestamp":1731383458,"startTime":"0","endTime":"0","summary":" * Capricor Therapeutics Inc 将于11月13日公布截至0001年1月1日的季度业绩报告,预计该公司的季度收入将出现下降。* LSEG 分析师对 Capricor Therapeutics Inc 的平均预期是每股亏损 36 美分。* 华尔街对 Capricor Therapeutics Inc 的 12 个月目标价中位数为 30.00 美元,高于其最新收盘价 19.54 美元。11月12日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","LENZ"],"gpt_icon":0},{"id":"2480068944","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.02%报20.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480068944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480068944?lang=zh_cn&edition=full","pubTime":"2024-11-01 02:56","pubTimestamp":1730400960,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日02时56分,Capricor Therapeutics, Inc.股票出现波动,股价快速跳水5.02%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为3.38%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101025600a2038667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101025600a2038667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2478930264","title":"Capricor Therapeutics, Inc.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478930264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478930264?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:10","pubTimestamp":1729869011,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时10分,Capricor Therapeutics, Inc.股票出现异动,股价大幅拉升5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025231011ab743247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025231011ab743247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2477755936","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.01%报21.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477755936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477755936?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:01","pubTimestamp":1729702864,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时01分,Capricor Therapeutics, Inc.股票出现异动,股价急速上涨5.01%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为1.06%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102401010598e3e0b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102401010598e3e0b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2477610218","title":"Capricor Therapeutics, Inc.盘中异动 大幅拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477610218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477610218?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:39","pubTimestamp":1729521549,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时39分,Capricor Therapeutics, Inc.股票出现异动,股价快速上涨5.36%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.61%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122391098e3d8e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102122391098e3d8e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"gpt_icon":0},{"id":"2477383856","title":"美国研究综述-中心空间、吉利德、Gitlab","url":"https://stock-news.laohu8.com/highlight/detail?id=2477383856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477383856?lang=zh_cn&edition=full","pubTime":"2024-10-21 19:25","pubTimestamp":1729509951,"startTime":"0","endTime":"0","summary":" 路透10月21日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Centerspace、Gilead 和 Gitlab。* 吉利德 :Leerink Partners将其评级从 \"跑赢大盘 \"上调至 \"跑赢大盘\"。* Gitlab Inc :Needham将其评级从 \"持有 \"上调至 \"买入 * Liberty Energy Inc :花旗集团将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLY","ELV","DDOG","ACLX","BANF","CHRD","EAT","CTRA","GTLB","LU1267930227.SGD","PLAY","CIVI","DD","BTAI","DTE","BLMN","ARRY","BKV","ANAB","LU2449327464.USD","AR","APA","CSR","FANG","LU2362541513.USD","CVS","CAKE","CPAY","OZK","NFLX","RCUS","CAPR","ARCB","AXP","LU1057294990.SGD","AN","CMA","AES","AMZN","PINE","LU1989764664.SGD","BSX","BWA","CCK","LNG","LU0061474960.USD","IE00BJTD4N35.SGD","UPST","BK4532","DVN","IE00BWXC8680.SGD"],"gpt_icon":1},{"id":"2477020510","title":"美国研究综述-美国运通、Capricor Therapeutics、旅行者","url":"https://stock-news.laohu8.com/highlight/detail?id=2477020510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477020510?lang=zh_cn&edition=full","pubTime":"2024-10-21 14:23","pubTimestamp":1729491822,"startTime":"0","endTime":"0","summary":" 路透10月21日 - 华尔街证券分析师周一调整了对美国运通、Capricor Therapeutics 和 Travelers 等多家美国上市公司的评级和目标价。要闻 * 美国运通 :TD Cowen将目标价从260美元上调至268美元 * Capricor Therapeutics :Piper Sandler给予该公司增持评级 * Fifth Third Bancorp :巴克莱将目标价从43美元上调至51美元 * Travelers :杰富瑞将目标价从235美元上调至256美元 * WEX Inc :花旗集团将目标价从280美元下调至260美元 以下是路透周一报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDB","LU0128525929.USD","PSX","KEY","MCB","UPST","NRDS","EEFT","ELV","LU0211331839.USD","QTWO","TRV","LU0823417737.USD","CPAY","LU1989772840.SGD","MP","PLL","PYPL","FOUR","ULTA","WEX","CCK","WAL","LU1914381329.SGD","LU1989764664.SGD","RF","OCFC","LU1989764748.USD","MDLZ","MMC","CAPR","LU1633808545.USD","BSX","LU2264538146.SGD","FFIN","MUR","LENZ","WAFD","FI","LU0237698245.USD","LU1989772923.USD","NOW","IE00B19Z3B42.SGD","LNG","FITB","PG","CMA"],"gpt_icon":1},{"id":"2477002031","title":"美国研究综述-美国运通、Capricor Therapeutics、旅行者","url":"https://stock-news.laohu8.com/highlight/detail?id=2477002031","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477002031?lang=zh_cn&edition=full","pubTime":"2024-10-21 14:23","pubTimestamp":1729491822,"startTime":"0","endTime":"0","summary":" 路透10月21日 - 华尔街证券分析师周一调整了对美国运通、Capricor Therapeutics 和 Travelers 等多家美国上市公司的评级和目标价。要闻 * 美国运通 :TD Cowen将目标价从260美元上调至268美元 * Capricor Therapeutics :Piper Sandler给予该公司增持评级 * Fifth Third Bancorp :巴克莱将目标价从43美元上调至51美元 * Travelers :杰富瑞将目标价从235美元上调至256美元 * WEX Inc :花旗集团将目标价从280美元下调至260美元 以下是路透周一报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","BK4173","NOW","INDB","ULTA","FITB","NRDS","LU0708994859.HKD","SOFI","FOUR","LU2023250843.SGD","LU2360107671.USD","QTWO","RF","WEX","LU2458330169.SGD","TRV","CMA","LU2430703251.USD","ELV","LU0648000940.SGD","LU0661504455.SGD","KEY","PLL","MMC","CPAY","WAL","LENZ","UPST","LNG","EEFT","OCFC","PSX","FFIN","PG","BSX","CCK","CAPR","LU1815333072.USD","WAFD","MDLZ","MP","MUR","MCB","LU2108987350.USD","FI","LU1291159041.SGD"],"gpt_icon":1},{"id":"2476061691","title":"BUZZ--美国股票走势-艾利丹尼森、Snap-On、Avadel Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=2476061691","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476061691?lang=zh_cn&edition=full","pubTime":"2024-10-18 00:01","pubTimestamp":1729180889,"startTime":"0","endTime":"0","summary":" * 个股走势的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 10月17日 - 华尔街周四上涨,标普500指数和道琼斯指数盘中触及纪录高位,受台积电乐观预期和月度零售销售超预期增长推动,表明美国消费者强劲。美东时间11:32,道琼斯工业平均指数 上涨0.4%,报43,238.32点。标普500指数 上涨0.29%,报5859.7点;纳斯达克综合指数 上涨0.36%,报18432.436点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STLD","WATT","LCID","TMO","MNQmain","SHAK","EFX","SLQT","CBSH","DFS","SBUX","ULTA","SDOW","SAGE","XRX",".DJI","MBIN","AVDL","WAT","AVY","ZUO","DDM",".IXIC","UDOW","GWW","CLMT","SNA",".SPX","WING","PIXY","PSQ","CSX","KZR","L","VSCO","CAPR","GRTS"],"gpt_icon":1},{"id":"2476120985","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌8.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476120985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476120985?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:32","pubTimestamp":1729171930,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时32分,Capricor Therapeutics, Inc.股票出现异动,股价大幅跳水8.78%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.18%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172132119f4a8652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172132119f4a8652&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2476147681","title":"BUZZ--美国股票走势-Meta Platforms、Elevance Health、Robinhood Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2476147681","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476147681?lang=zh_cn&edition=full","pubTime":"2024-10-17 19:58","pubTimestamp":1729166308,"startTime":"0","endTime":"0","summary":"** Nvidia Corp :盘前上涨 3.1** Broadcom Inc :盘前上涨 2.8** 英特尔 :盘前上涨1.2%BUZZ - 台积电第三季度业绩强劲,美国芯片股上涨 ** Elevance Health Inc :盘前下跌12.1%BUZZ - 年度利润预期下调后下跌 ** 美国铝业公司 :盘前上涨6.6%BUZZ - 在第三季度核心利润超出预期后上涨,摩根大通上调PT ** Capricor Therapeutics Inc :盘前下跌 8.6%BUZZ - 因定价发行 7,500 万美元股票而下跌 ** Gritstone bio Inc :盘前下跌10.2%BUZZ - 因裁员而下跌","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRTS","IE00BMPRXN33.USD","BK4532","LU0266013472.USD","L","BK4559","META","HK0000320223.HKD","LU2362540622.SGD","KMI","GB00B4QBRK32.GBP","LU0149725797.USD","BK4587","CAPR","2NVD.UK","LU0345770993.USD","LU0882574055.USD","BK4527","SG9999014880.SGD","EXPE","LU0348723411.USD","BK4515","IE00B4JS1V06.HKD","SG9999001077.SGD","3NVD.UK","LU0256863811.USD","ELV","TRV","IE0009G5SDU7.USD","SG9999014914.USD","BK4576","IE00BYXW3230.USD","SG9999015952.SGD","IE00B775H168.HKD","BK4548","BK4512","LCID","AA","SHW","LU0187121727.USD","BK4551","CSX","HOOD","LU2505996509.AUD","IE0004445239.USD"],"gpt_icon":1},{"id":"2476667148","title":"BUZZ-Capricor Therapeutics 因定价发行 7,500 万美元股票而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2476667148","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476667148?lang=zh_cn&edition=full","pubTime":"2024-10-17 18:40","pubTimestamp":1729161646,"startTime":"0","endTime":"0","summary":" 10月17日 - ** Capricor Therapeutics 股价在隔夜跟风定价后盘前下跌 12%,至 18.05 美元。** 总部位于圣迭戈的生物技术公司 以17美元的价格出售了 () ~440万股股票,总收益为750万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4127","BK4139","CAPR","PIPR"],"gpt_icon":0},{"id":"2476976297","title":"BUZZ-Capricor Therapeutics 因计划发行股票而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2476976297","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476976297?lang=zh_cn&edition=full","pubTime":"2024-10-17 04:41","pubTimestamp":1729111308,"startTime":"0","endTime":"0","summary":" 10月16日 - ** Capricor Therapeutics 股价在延时交易中下跌8.6%,至18.75美元,该公司正寻求融资 ** 总部位于圣地亚哥的生物技术公司宣布 股票发行;交易规模未披露** 派博桑德勒公司和奥本海默公司担任账簿管理人** 公司打算将募集资金净额用于候选产品的继续开发和生产、营运资金和一般公司用途** CAPR 股价周三收盘下跌 5%,报 20.51 美元** 公司拥有约 3 254 万股已发行股票,市值约 6.68 亿美元,公众持股量约 2 493 万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2475916853","title":"Capricor Therapeutics, Inc.盘中异动 早盘急速下跌5.00%报20.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475916853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475916853?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:25","pubTimestamp":1729088743,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时25分,Capricor Therapeutics, Inc.股票出现波动,股价快速下挫5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.99%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016222543971a0a61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016222543971a0a61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2475635301","title":"Capricor Therapeutics, Inc.盘中异动 早盘大幅上涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475635301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475635301?lang=zh_cn&edition=full","pubTime":"2024-10-15 23:08","pubTimestamp":1729004898,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日23时08分,Capricor Therapeutics, Inc.股票出现异动,股价大幅上涨5.16%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.54%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015230819ab6a4921&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015230819ab6a4921&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CAPR"],"gpt_icon":0},{"id":"2475399781","title":"Capricor Therapeutics, Inc.盘中异动 快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475399781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475399781?lang=zh_cn&edition=full","pubTime":"2024-10-14 23:24","pubTimestamp":1728919469,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日23时24分,Capricor Therapeutics, Inc.股票出现波动,股价大幅拉升5.01%。Capricor Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。Capricor Therapeutics, Inc.公司简介:Capricor Therapeutics Inc是一家总部设在美国的生物技术公司,专注于发现、开发和商业化用于治疗疾病的一流生物疗法,重点是杜兴氏肌肉萎缩症和其他医疗条件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014232429ab6a009c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014232429ab6a009c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"gpt_icon":0},{"id":"2474010023","title":"BUZZ--美国股票走势-沃尔玛、加密货币、银行","url":"https://stock-news.laohu8.com/highlight/detail?id=2474010023","media":"Reuters","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474010023?lang=zh_cn&edition=full","pubTime":"2024-10-12 01:43","pubTimestamp":1728668607,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 10月11日 - 周五开盘时,华尔街主要股指涨跌不一,交易员在生产者价格数据公布后维持对美联储11月降息25个基点的押注不变,而特斯拉股价暴跌拖累了纳斯达克指数。美东时间13:08,道琼斯工业平均指数 上涨0.71%,报42,754.93点。标普500指数 上涨0.45%,报5,805.8点;纳斯达克综合指数 上涨0.16%,报18,311.445点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KMI","DOG",".DJI","EZBC","DJX","RIOT","COIN","TSBX","QID","BRRR","TSLA","SDOW","BAC","COP","ROCK","NEM",".SPX","BTCW","AEHR","HODL","MNQmain","NCNC","UDOW","FBTC","FROG","BITO","FAST","LYFT","DDM","CMG","DEFI","DXD","NQmain","PSQ","SQQQ","JPM","WYNN","AOS","MBLY",".IXIC","BTCO","GBTC","TQQQ","WMT","CAPR","OIS"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.capricor.com","stockEarnings":[{"period":"1week","weight":-0.0553},{"period":"1month","weight":-0.0926},{"period":"3month","weight":3.6995},{"period":"6month","weight":2.0016},{"period":"1year","weight":5.0422},{"period":"ytd","weight":2.8057}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,专注于开发转化细胞和外泌体疗法,用于治疗Duchenne肌营养不良症(DMD),这是一种罕见的肌肉营养不良症,会导致肌肉退化和过早死亡,以及其他医疗需求未得到满足的疾病。自成立以来,该公司投入了大量资源开发CAP-1002和他们的其他候选产品,包括他们的外泌体平台,开发他们的制造流程,为公司配备人员,并为这些业务提供行政支持。该公司没有任何获准销售的产品。公司能否最终产生足以实现盈利的任何产品收入,将取决于用于治疗DMD和其他候选产品的CAP-1002的成功开发、批准和最终商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.171511},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.017849},{"month":3,"riseRate":0.555556,"avgChangeRate":0.019788},{"month":4,"riseRate":0.4,"avgChangeRate":0.465721},{"month":5,"riseRate":0.3,"avgChangeRate":-0.145751},{"month":6,"riseRate":0.6,"avgChangeRate":0.038271},{"month":7,"riseRate":0.4,"avgChangeRate":0.099816},{"month":8,"riseRate":0.6,"avgChangeRate":0.032614},{"month":9,"riseRate":0.4,"avgChangeRate":0.368975},{"month":10,"riseRate":0.1,"avgChangeRate":-0.099537},{"month":11,"riseRate":0.4,"avgChangeRate":-0.088121},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.114866}],"exchange":"NASDAQ","name":"Capricor Therapeutics Inc","nameEN":"Capricor Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Capricor Therapeutics Inc,CAPR,Capricor Therapeutics Inc股票,Capricor Therapeutics Inc股票老虎,Capricor Therapeutics Inc股票老虎国际,Capricor Therapeutics Inc行情,Capricor Therapeutics Inc股票行情,Capricor Therapeutics Inc股价,Capricor Therapeutics Inc股市,Capricor Therapeutics Inc股票价格,Capricor Therapeutics Inc股票交易,Capricor Therapeutics Inc股票购买,Capricor Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}